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Abstract
Background. Ischaemic kidney injury continues to play
a dominant role in the pathogenesis of acute renal failure
(ARF)inmanysurgicalandmedicalsettings.Amajorevent
in the induction of renal injury is related to the generation
of oxygen-free radicals. Hyperbaric oxygen therapy (HBO)
is indicated for treatment of many ischaemic events but not
for ARF. Therefore, the present study examined the effects
of HBO on kidney function and renal haemodynamics in
rats with ischaemic ARF.
Methods. Renal ischaemia was induced by unilateral renal
artery clamping (45 min) in rats. Within 24 h following
ischaemia, rats were treated twice with HBO of 100% O2
at 2.5 absolute atmospheres for 90 min each (+HBO). Un-
treated rats (−HBO) served as a control. Forty-eight hours
later, GFR, RBF and endothelial-dependent vasorelaxation
weremeasured.Inaddition,theimmunoreactivestainingof
4-hydroxy-2-noneal (4-HNE), a major product of endoge-
nous lipid peroxidation, and superoxide dismutase (SOD)
were assessed.
Results. In the −HBO group, GFR was reduced by 94%
compared with the untouched normal kidney (ischaemic:
0.06 ± 0.03 ml/min, normal: 1.02 ± 0.13 ml). In contrast,
in the +HBO group, GFR of the ischaemic kidney (0.36 ±
0.07 ml/min) was reduced only by 68% com-
pared with the contralateral normal kidney (1.12 ±
0.12 ml/min). In line with these findings, HBO improved
the vasodilatory response to ACh as expressed in enhance-
mentofbothtotalandregionalrenalbloodflow.Inaddition,
HBO reduced the formation of 4-HNE by 33% and 76%
and increased SOD by 30% and 70% in the cortex and
outer stripe region of the medulla of the ischaemic kidney,
respectively.
Conclusion. HBO attenuates the decline in GFR following
renal ischaemia, and improves endothelial-dependent va-
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sorelaxation, suggesting that treatment with HBO may be
beneficial in the setting of ischaemic ARF.
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Introduction
Acute renal failure (ARF) continues to be a frequent threat-
ening complication following trauma and complex surgical
procedures, and in patients hospitalized in intensive care
units [1,2]. Despite the increasing awareness of this syn-
drome, the advances in clinical care and extensive research
of its pathophysiology, the mortality from ARF remains
high and has not changed significantly during the last sev-
eral decades [2].
Ischaemic kidney injury continues to play a dominant
role in the pathogenesis of ARF in many surgical and med-
ical settings. Recent investigations into the mechanisms of
renal damage following ischaemia in animal models sug-
gest an early contribution of endothelial dysfunction and a
local inflammatory response as major components of the
evolving ischaemic injury to the kidney [3–5]. As a conse-
quence of these events, the recovery of blood supply to the
ischaemickidneymaybesignificantlydelayedandreduced
leading to further impairment of tissue oxygenation.
A major event in the induction of tissue injury is related
to the generation of oxygen-free radicals and the associated
oxidative and nitrosative stress [4–6]. In particular, it has
been demonstrated that the highly reactive hydroxyl radi-
cal and the nitric oxide (NO) metabolic product, peroxyni-
trite (ONOO−), are generated during the renal reperfusion
phase and have diverse cytotoxic properties. These include
damage to DNA, protein oxidation and nitrosylation, lipid
peroxidation and induction of apoptosis [3,6,7].
Hyperbaric oxygen therapy (HBO) is defined as a treat-
ment in which a patient is intermittently exposed to 100%
oxygen while the treatment chamber is pressurized to a
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pressure above sea level (>1 ATA, 760 mmHg) [8]. HBO
therapy has been used in a number of medical conditions
with a proven efficacy in a limited number of disorders
[8–10]. In ischaemic rat tissues, HBO was shown to inhibit
neutrophil adherence to the wall of ischaemic vessels and
to decrease post-ischaemic vasoconstriction in skin grafts
[11]. Furthermore, we showed in our laboratory that HBO
has striking beneficial anti-inflammatory effects on exper-
imental colitis in rats [12]. In several experimental condi-
tions,HBOhasbeenclaimedtoexertitsbeneficialeffectsin
part by increasing the activity of Cu/Zn superoxide dismu-
tase (Cu/Zn-SOD) and other antioxidant cellular defence
mechanisms, thereby altering the balance between genera-
tion and removal of oxygen-free radicals [13–15].
Several investigators reported that HBO treatment may
modulate kidney function in rats with sepsis [16], rats
with adriamycin-induced nephrotic syndrome [17] and
experimental cyclosporine nephrotoxicity [18]. Recently,
Solmazgul et al. [19] demonstrated that HBO attenu-
ated the elevation in plasma creatinine and histological
damage in Sprague-Dawley rats subjected to renal is-
chaemia/reperfusion injury. Moreover, HBO treatment has
been reported to be beneficial in the management of the
musclecompartmentsyndrome,adevastatingcomplication
ofcrushsyndrome,wherekidneyfunctionisoftenimpaired
[20] (reviewed in Reis ND and Better OS [21]).
Here we report that HBO treatment following re-
nal ischaemia/reperfusion attenuated the deterioration in
glomerular filtration rate (GFR) in the ischaemic kidney,
in parallel with an improvement in the antioxidant/oxidant
balance.
Materials and methods
Studies were conducted on male Sprague-Dawley rats
(Harlan Laboratories, Jerusalem, Israel) weighing 280–
320 g. Animals were maintained on regular rodent chow
(0.45% NaCl) and water ad libitum prior to experiments.
The experiments were conducted according to the guide-
lines of the institutional Animal Use and Care Committee,
Technion, Israel.
In vivo protocols
Induction of ischaemic ARF. Forty-eight hours prior to
clearanceandrenalhaemodynamicstudies,ratswerelightly
anaesthetized by intraperitoneal injection of Nembutal
(pentobarbitone sodium, 30 mg/kg BW) and placed on a
heated surgical table to maintain body temperature. The
left kidney was then exposed through a flank incision, and
renal ischaemia was induced by complete occlusion of the
left renal artery for 45 min by a surgical clamp. The con-
tralateral, right kidney was left untouched and served as an
internal control. Following ischaemia, the clamp was re-
leased, the incision was sutured and the rat was allowed to
recover.
Hyperbaric oxygen treatment. Rats with left kidney is-
chaemia were randomly divided into two experimental
groups. The first group (+HBO, n = 9) was placed in a
hyperbaric chamber for two HBO treatments of 90 min
each, 2 h and 22 h after renal ischaemia. This protocol was
chosen based on previous experiments from our laboratory
in rats with crush syndrome where HBO exerted beneficial
effects on muscle function (unpublished observations). The
chamberwaspressurizedwith100%oxygento2.5absolute
atmospheres (ATA). The second group (−HBO, n = 6) was
left at room atmosphere for 48 h, and served as a control
for group 1.
Clearance studies. On the second day, ∼48 h after renal
ischaemia, animals from both groups were anaesthetized
by injection of Inactin (100 mg/kg BW, i.p.), and prepared
forclearanceexperimentsaspreviouslydescribedfromthis
laboratory [22,23]. In short, after tracheotomy, the rat was
placed on a heated surgical table and the left carotid artery
and right jugular vein were cannulated by polyethylene
tubing (Portex, Hythe, Kent, UK) for continuous moni-
toring of mean arterial pressure (MAP) and infusion of
various solutions, respectively. A solution of 2% inulin
in 0.9% saline was infused at a rate of 1.0–1.5% BW/h,
throughout the experiment. The abdominal cavity was then
exposed through a mid-abdominal incision, and the left
ureter was identified, separated from the surrounding fat
and cannulated by a PE-10 tube for urine collection. The
urinary bladder was exposed, and a funnel-shaped PE-50
catheterwasinsertedforurinecollectionfromthecontralat-
eral right kidney. Urine was collected separately from each
kidney into pre-weighed tubes containing mineral oil, and
the urine volume was measured gravimetrically. Following
surgery, a 60-min equilibration period was allowed before
the first clearance period was obtained. Four clearance pe-
riods of 20–30 min each were obtained, and blood samples
(0.3 ml) were withdrawn every second clearance pe-
riod. Blood samples were separated by centrifugation, and
plasma and urine aliquots were kept at −20◦C for determi-
nationofinulinconcentration.Foreachexperimentalgroup,
GFRwasdeterminedfortheleftischaemickidney,theright
control kidney and the ratio of GFR in ischaemic/control
kidneys were calculated.
Renal haemodynamic measurements
(A) Total renal blood flow: to evaluate the effects of
HBO on renal haemodynamic parameters, studies
were conducted in rats subjected to unilateral is-
chaemia 48 h earlier, treated (+HBO, n = 9) or
untreated (−HBO, n = 6) with hyperbaric oxygen,
as described in the previous protocol. An additional
groupofsham-operatedcontrolrats(n=6)wasused
to test the effects of the operation itself on relevant
haemodynamic parameters. In these rats, a flank in-
cision was performed, but the left renal artery was
not clamped. The rats were anaesthetized by Inactin
as described in the previous protocol. The left re-
nal artery was exposed through a mid-abdominal
incision. Measurements of total renal blood flow
(RBF) were performed by an ultrasonic flowmeter
(model T206, Transonic Corp., Ithaca, NY, USA),
using a flow-probe (1RB) placed around the left re-
nalartery,aspreviouslydescribed[23,24].MAPwas
continuously monitored by a pressure transducer,
and RVR was calculated on-line according to the
formula RVR = MAP/RBF using data acquisition430 I. Rubinstein et al.
software (Labtech Notebook
R ). After surgery and
equilibration, baseline measurements were obtained
for 20 min. The endothelial-dependent renal vasodi-
latation in response to incremental doses of acetyl-
choline (ACh) infusion (1, 10 and 100 µg/kg/min,
for20mineachdose,followedbyarecoveryperiod)
was determined as previously described [22].
(B) Intrarenal blood flow: to evaluate the effects of
HBOonintrarenalhaemodynamicparameters,stud-
ies were conducted in rats subjected to unilateral
ischaemia 48 h earlier, treated (+HBO, n = 9)
or untreated (−HBO, n = 6) with hyperbaric oxy-
gen. For this purpose, the left kidney was ex-
posed through a mid-abdominal incision. Cortical
and medullary blood flow (CBF and MBF, respec-
tively) were measured simultaneously by a dual
channel laser-Doppler flowmeter (Master Perimed
AB, model 4001) using two needle probes as pre-
viously described [23]. ACh was administered at a
dose of 10 µg/kg/min, and CBF was measured at 5-
min intervals for 30 min after administration of the
drug. The location of the laser needle probes was
verified at the end of each experiment.
In vitro protocols
To test the hypothesis that HBO exerted its beneficial ef-
fects on renal function in part by improving the antioxi-
dant/oxidant balance, we evaluated the immunohistochem-
ical localization of the activities of the antioxidant enzyme
Cu/Zn-SOD and that of 4-hydroxy-2-noneal (4-HNE), a
marker of lipid peroxidation.
Theunclamped,normalkidneyandtheischaemickidney
were removed 48 h following ischaemia/reperfusion in the
−HBO and +HBO groups under pentobarbitone sodium
anaesthesia. Kidneys were fixed in 10% neutral buffered
formalin, dehydrated in ascending ethanols and embedded
in paraffin wax. Five-micrometre thick microtome sections
were mounted on SuperFrost
R  Plus slides (Menzel-Glaser,
Braunschweig, Germany).
Immunostainingwasperformedwithanantibodyagainst
4-HNE (1:600, Alpha Diagnostic Inc., San Antonio,
TX, USA) and anti-superoxide dismutase–CuZn enzyme
(1:600, Oxis International Inc., Portland, OR, USA), using
a histostain-SP kit (Zymed Laboratories, San Francisco,
CA, USA).
The immunoreactive stained areas of the end-products
were observed using an Olympus CH-40 brightfield mi-
croscope (Olympus, Tokyo, Japan) with an attached CCD
camera. The areas observed and analysed in the sections
weretakenfromthemedullaandfromthroughoutthecortex
apartfromthatimmediatelyunderthecapsule.Quantitative
histomorphometric analysis was determined in randomly
standardized fields of view by means of commercial image
analysis software (analySIS
R  3.0, Soft Imaging System,
M¨ unster, Germany).
Chemical analysis
Inulin concentration in plasma and urine samples was de-
termined by the anthrone method [25]. GFR was equated
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Fig. 1. (A) Effect of HBO treatment on glomerular filtration rate (GFR)
of control and ischaemic kidneys. (B) GFR ratio of ischaemic/normal
kidney in the +HBO group and the −HBO group. n = 6–9 in each
group. (A) shows that in the −HBO group, GFR was reduced by 94%
compared with the untouched normal kidney. In contrast, in the +HBO
group GFR of the ischaemic kidney was reduced only by 68% compared
with the contralateral normal kidney. (B) demonstrates that the ratio of
GFR of ischaemic/normal kidney is significantly higher in the +HBO
group compared with the −HBO group.
determined by flame photometry (model IL 943, Instru-
mentation Laboratories, Milano, Italy).
Statistical analysis
The paired student t-test (for comparison between the is-
chaemic and untouched, normal, kidney in the same ani-
mal) and either the unpaired t-test or analysis of variance
(ANOVA), as appropriate, were used for statistical analysis
of the data. A P-value of 0.05 or less was considered statis-
tically significant. Data are expressed as means ± standard
error of mean (S.E.M).
Results
Clearance protocols
Figure 1 summarizes the results of the clearance exper-
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group,48hafterrenalischaemia,GFRwasreducedby94%
compared with the untouched, normal kidney (ischaemic:
0.06 ± 0.03 ml/min, normal: 1.02 ± 0.13 ml/min). In
contrast, in the +HBO group, GFR in the ischaemic kid-
ney (0.36 ± 0.07 ml/min) was reduced only by 68%
compared with the contralateral normal kidney (1.12 ±
0.12 ml/min). The difference in GFR of the ischaemic kid-
neys in the groups treated or untreated with HBO was
statistically significant (P < 0.05, Figure 1). Also, when
expressed as GFR of ischaemic/normal kidney, this ratio
was significantly higher in the +HBO group compared
with the −HBO group (0.39 ± 0.1 versus 0.08 ± 0.05,
respectively, P < 0.05, Figure 1B). In spite of the im-
provement in GFR following HBO treatment, there was
no detectable change in either fractional sodium excretion
(−HBO: 0.34 ± 0.09, +HBO: 0.33 ± 0.07, P = N.S.)
or in the urine flow rate (−HBO: 3.86 ± 0.86 µl/min,
+HBO: 2.25 ± 0.31 µl/min, P = N.S.) in the ischaemic
kidney.
Renal and intrarenal haemodynamics measurements
Baseline values of MAP, RBF and calculated RVR in the
sham-operated control group and in the ischaemic kidney
of −HBO and +HBO groups are summarized in Figure 2.
BaselineMAPdidnotdiffersignificantlyinthethreeexper-
imental groups. Baseline RBF decreased by 26% in +HBO
rats versus −HBO rats. However, both were significantly
lower compared with normal control kidney. In line with
these measurements, calculated baseline RVR was higher
(by 52%) in the ischaemic kidney of the +HBO group
compared with the −HBO group.
The results of the endothelial-dependent renal vasodi-
latation in response to ACh administration are depicted in
Figure 3. As shown, infusion of incremental doses of ACh
produced a similar decrease in MAP in the three exper-
imental groups (sham, ischaemic −HBO and ischaemic
+HBO), followed by a similar recovery response upon
cessation of ACh infusion. In spite of the decrease in MAP,
there was a dose-related rise in RBF in response to ACh
in all groups, apparently as a result of an endothelial-
dependent renal vasodilatation. Of interest, treatment with
HBO (ischaemic kidney of +HBO) significantly improved
the renal vasodilatory response to ACh as compared to is-
chaemic kidney of −HBO. Indeed, as shown in the lower
panel of Figure 3, there was a dose-dependent decrease
in RVR in all three experimental groups, especially in is-
chaemic kidney of +HBO rats. This notion is further sup-
ported by the measurements of intrarenal blood flow in
response to the ACh as depicted in Figure 4. As shown, ad-
ministrationofAChtocontrolratscausedagradualincrease
in CBF, which reached maximal magnitude of 35% ± 8%
above baseline value at 30minafterthedrug injection(Fig-
ure 4A), whereas MBF did not change significantly (Fig-
ure 4B). In contrast, in the ischaemic kidney of the −HBO
group,AChelicitedanattenuatedincreaseinCBF(18±3%
peakincreaseat30minafterinjectionofthedrug).Thecor-
tical vasodilatory response to ACh significantly improved
following HBO treatment (CBF reached a peak increase
of 28 ± 11% at 30 min after injection of the drug). These
findings may explain the observed stimulatory effects of
HBO on total RBF, and suggest that treatment with HBO
may improve endothelial-dependent vasorelaxation medi-
ated by eNOS. It should be emphasized that basal CBF
Fig. 2. Baseline values of (A) mean arterial pressure (MAP), (B) renal blood flow (RBF) and renal vascular resistance (RVR), in the sham-operated
control group and in the ischaemic kidney of −HBO and +HBO treated groups, 48 h after the induction of ischaemia. n = 6–9 in each group. Baseline
values of MAP, RBF and calculated RVR in the sham-operated control group and in the ischaemic kidney of −HBO and +HBO groups are summarized
in Figure 3. It is clear that baseline RBF decreased by 26% in +HBO rats versus −HBO rats. However, both were significantly lower compared with
normal control kidney. Since MAP does not differ significantly in the three experimental groups, the calculated baseline RVR is higher (by 52%) in the


























































































Fig. 3. Effects of acetylcholine (ACh) administration (1, 10 and
100 µg/kg/min) on (A) mean arterial pressure (MAP), (B) renal blood
flow (RBF) and (C) renal vascular resistance (RVR), in the sham-operated
control group and in the ischaemic kidney of −HBO and +HBO groups
48 h after the induction of ischaemia. n = 6–9 in each group. ∗P < 0.05
versus sham. As shown, infusion of incremental doses of ACh produced
a similar decrease in MAP in association with rise in RBF in response to
ACh in all the groups, apparently as a result of an endothelial-dependent
renal vasodilatation.
of normal kidney, ischaemic kidney and ischaemic kidney
following HBO treatment was not significantly different:
309.9 ± 11.95; 323.9 ± 25.4 and 330.6 ± 26.0 perfusion
units, respectively. Likewise, baseline MBF values of these
experimentalgroupswerecomparable:82.05±2.17;94.08
± 5.68 and 95.30 ± 4.41 perfusion units, respectively.
Immunohistological staining
Figure 5 summarizes the results of immunostaining for 4-
HNE,amarkerforlipidperoxidation.Immunostainingof4-
HNEwaslocalizedprimarilyintherenaltubularcellsofthe
outer stripe region of the medulla of the ischaemic kidneys,
and was almost undetectable in the cortex of normal or
ischaemic kidneys of both +HBO and −HBO groups. The
vascular elements and the glomeruli were unstained in all
cases, treated and controls. In contrast to the findings in the
cortex, the area in the outer stripe of the medulla stained for
4-HNE was significantly lower in the ischaemic kidneys of
rats treated with hyperbaric oxygen than in untreated rats
(+HBO: 12.7 ± 0.84%, −HBO: 53.1 ± 1.55, P < 0.001,
Figure 5).
Figure 6 summarizes the immunohistological data on
Cu/Zn-SOD in the cortex and outer stripe region of the
medulla of control and ischaemic kidneys treated with or
withoutHBO.Inthecontrol,untouchedkidneys,immunos-
taining for Cu/Zn-SOD in the cortex and the medulla was
negligible.TherewasamarkedincreaseinCu/Zn-SODim-
munoreactive staining in the outer stripe of the medulla of
the ischaemic kidneys in both −HBO and +HBO groups,
compared with the control non-ischaemic kidneys. How-
ever, in the +HBO group, the percentage of staining for
Cu/Zn-SODwassignificantlyhigherthanthatinthe−HBO
group (+HBO: 17.3 ± 1.11%, −HBO: 10.2 ± 0.83%, P <
0.001, Figure 6).
Thus, HBO treatment was associated with an increase
in the immunohistochemical staining of the antioxidant
Cu/Zn-SOD and a parallel decrease in the immunohisto-
chemicalstainingforthelipidperoxidationmarker,4-HNE,
in the outer stripe of the medulla of the ischaemic kidneys.
Discussion
Thefindingsofthepresentstudyprovidenovelinformation
on the mechanisms underlying ARF and support the use
of HBO for treatment of ischaemic renal injury. Our data
clearly demonstrate that treatment with HBO substantially
attenuated the reduction in GFR characterizing ARF. The
HBO-induced renal vasodilatation was associated with a
significant increase in total RBF in response to ACh, due
to enhanced perfusion of the renal cortex in the ischaemic
kidney. Despite the improvement in renal haemodynamics,
HBO did not cause a concomitant increase in urine flow or
sodium excretion. Moreover, our findings demonstrate that
the improvement in renal function following HBO occurs
in parallel with a similar increase in the antioxidant/oxidant
ratio in the ischaemic kidney. This suggests that the latter
mechanism may partially contribute to the improvement in
renal function in kidneys recovering from ischaemic injury,
and support the use of HBO for treatment of ARF.
Previously, Solmazgul et al. [19] demonstrated that
HBO treatment produced marked protection against is-
chaemia of 30 min followed by 24-h reperfusion after the
right nephrectomy. These authors applied HBO therapy for
60 min, starting at the initial 15th min of reperfusion. An-
imals treated with HBO showed regression of the elevated
plasma creatinine and blood urea nitrogen levels to nor-
mal concentrations in association with reversal of tubular
damage and neutrophil infiltration. However, the mecha-
nisms underlying the beneficial effects of HBO therapy
were not studied in this study. Our data clearly show that
HBOtreatmentpartiallycorrectedthedeclineinGFRcom-
plicating ARF and provide new insights into the mecha-
nisms underlying the therapeutic actions of HBO in the I/RHyperbaric oxygen treatment improves GFR in rats with ischaemia/reperfusion renal injury 433
Fig. 4. Effects of acetylcholine (ACh) administration (10 µg/kg/min) on (A) cortical blood flow (CBF) and (B) medullary blood flow (MBF) in the
sham-operated control group and in the ischaemic kidney of −HBO and +HBO groups 48 h after the induction of ischaemia. n = 6–9 in each group.
It is evident that administration of ACh to control rats caused a gradual increase in CBF, whereas MBF did not change significantly. In contrast, in the
ischaemic kidney of the −HBO group, ACh elicited an attenuated increase in CBF. The cortical vasodilatory response to ACh significantly improved
following HBO treatment. These findings may explain the observed stimulatory effects of HBO on total RBF, and suggest that treatment with HBO
may improve endothelial-dependent vasorelaxation mediated by eNOS. P < 0.05 vs. −HBO.
Fig. 5. Representative pictures of 4-HNE staining in the medulla of −HBO (A)a n d+HBO (B) ischaemic kidneys (objective ×20). (C) Percentage
staining area of 4HNE in the renal outer strip of the outer of −HBO and +HBO of control and ischaemic kidneys. n = 6–9 in each group. This
figure indicates that 4-HNE is localized primarily in the renal tubular cells of the outer stripe of the medulla of the ischaemic kidneys, and is almost
undetectable in the cortex. The area of the outer stripe of the medulla stained for 4-HNE is significantly less than in the ischaemic kidneys of rats treated
with hyperbaric oxygen than in untreated rats.
model of ARF. For instance, the beneficial effects of HBO
on GFR in the +HBO group could be attributed to the
observed concurrent improvement in endothelial function
of the injured kidney following HBO. In that respect, rats
withARFthatweretreatedwithHBOdisplayedamorepro-
nounced endothelial-dependent vasorelaxation in response
to ACh compared with control animals, and the −HBO
group. This improvement was accompanied by a concomi-
tant decrease in the 4-HNE level in renal tissue. 4-HNE, a
major product of endogenous lipid peroxidation, is consid-
eredasareliableindicatorofoxidativedamage[26,27].Itis
wellestablishedthatROSdirectlycausevasoconstrictionin434 I. Rubinstein et al.
Fig. 6. Representative pictures of CuZn-SOD staining in the medulla of −HBO (A)a n d+HBO (B) ischaemic kidneys (objective × 20). (C) Percentage
staining area of CuZn-SOD in the renal medulla of −HBO and +HBO control and ischaemic kidney. n = 6–9 in each group. It is evident that
immunostaining for Cu/Zn-SOD in the cortex and the outer stripe of the medulla of untouched kidneys is negligible. A marked increase in Cu/Zn-SOD
immunoreactive staining in the outer stripe of the medulla of the ischaemic kidneys in both −HBO and +HBO groups, compared with the control
non-ischaemic kidneys, is notable. However, in the +HBO group, the percentage of staining for Cu/Zn-SOD is significantly higher than that in the
−HBO group. Thus, HBO treatment induces an increase in the immunohistochemical staining of the antioxidant Cu/Zn-SOD in the outer stripe of the
medulla of the ischaemic kidneys.
kidney microcirculation [28]. Furthermore, they indirectly
increase vascular tone by affecting the action or production
ofvasodilatorysubstancesofendothelialoriginsuchasNO
[29]. Therefore, the observed increased oxidative stress in
the ischaemic kidney probably composes additional mech-
anism that could be responsible for the renal dysfunction
occurring during ARF. The latter is compatible with our
findingsthatthebeneficialeffectofHBOtreatmentonGFR
was accompanied by enhancement of SOD abundance and
decline in 4-HNE in the renal tissue. Similar results were
obtained in sepsis-induced ARF, where renal dysfunction
was associated with the reduction of renal SOD and cata-
lase (CAT) activities and the increase in malondialdehyde
(MDA) levels [16,30]. Interestingly, GFR recovered to nor-
mal values along with the reduction in oxidative damage
by either HBO treatment [16] or administration of an SOD
mimetic [29]. Beneficial renal effects of antioxidant agents
such as vitamin E, edaravone (radical scavenger) and mela-
tonin were also reported in experimental models of cy-
closporine nephrotoxicity [31], ischaemic ARF [32] and
glycerol-induced ARF [33], respectively. Taken together,
these studies indicate that oxygen-free radicals play a ma-
jorroleinrenalinjuryofdifferentaetiologiesandthatHBO
treatment has a beneficial effect on renal dysfunction. The
beneficialrenaleffectofHBOcouldbeattributedtoitsanti-
oxidative capacity. This notion is supported by our findings
that HBO augmented the SOD immunoreativity in the re-
nal tissue to normal levels and abolished the increase in
4-HNE. Similarly, several studies have demonstrated that
HBO treatment increased the SOD and/or CAT activities in
rat extensor digitorum longus muscle [13], in pancreas and
erythrocytes of rats with induced acute necrotizing pancre-
atitis [34], in the lungs of rats and guinea pigs [35] and in
the erythrocytes of human patients with multiple sclerosis
[36].
The stimulatory effects of HBO treatment on the
endothelial-dependent vasorelaxation induced by ACh in
the ischaemic kidney hint that HBO treatment improves
the function of the NO system, which plays an important
role in the regulation of renal haemodynamic and kidney
function. In line with these findings, several studies have
shown that HBO increases the NO levels in the perivascu-
lar part of the aorta [35], and the brain [37,38]. Similarly,
Cabigas and coworkers [39] have recently demonstrated a
cardioprotective effect of HBO in rats subjected to myocar-
dial ischaemia/reperfusion. The authors suggested that the
conferred cardioprotection was due to HBO-mediated in-
creased association between heat-shock protein 90 (hsp90)
and eNOS, which further augmented NO production [39].
Additionalstudiesarerequiredtoelucidateifsimilarmech-
anisms contributed to the enhanced recovery of GFR in our
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Nevertheless, despite the restoration and even enhanced
endothelial-dependent response to ACh 48 h after is-
chaemic injury, baseline RBF was still lower in the −HBO
and +HBO ischaemic kidneys compared with the non-
ischaemic control kidney. This could reflect the predom-
inant effects of various vasoconstrictor, NO-independent,
systems that are still present at this post-ischaemic stage
and may control renal haemodynamics.
Since basal RBF was lower in the +HBO group as com-
pared to the −HBO group, this further decline in basal
RBF following HBO treatment is consistent with the vaso-
constrictive action of hyperoxygenation [40]. The mecha-
nism(s) by which HBO treatment caused the increase in
GFR were not clarified in the present study. Thus, the find-
ing that despite the reduction in basal RBF, HBO caused
a concomitant increase in GFR of the ischaemic kidneys
might suggest that HBO induced a preferential vasocon-
striction of the efferent arteriole. Alternatively, it might be
speculated that the observed enhancement in GFR was not
relatedtohaemodynamicchanges,butrathertoanimprove-
ment in the tubular integrity and function of the injured
nephrons. Further studies will be required to elucidate the
exact mechanisms of GFR improvement and the contribu-
tion of the alterations to oxidant/antioxidant balance in that
regard.
Insummary,thisstudydemonstratesthatacuteischaemic
renal injury is associated with enhancement of renal oxida-
tive stress and that HBO treatment has a potential in the
recovery of GFR by improving the antioxidant/oxidant bal-
ance in the ischaemic kidney.
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